Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
Musso G, Cassader M, De Michieli F, Paschetta E, Pinach S, Saba F, Bongiovanni D, Framarin L, Berrutti M, Leone N, Corvisieri S, Parente R, Molinaro F, Sircana A, Bo S, Gambino R. Musso G, et al. Among authors: berrutti m. Hum Mol Genet. 2017 May 1;26(9):1747-1758. doi: 10.1093/hmg/ddw400. Hum Mol Genet. 2017. PMID: 28334911
TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.
Musso G, Cipolla U, Cassader M, Pinach S, Saba F, De Michieli F, Paschetta E, Bongiovanni D, Framarin L, Leone N, Berrutti M, Rosina F, Corvisieri S, Molinaro F, Sircana A, Gambino R. Musso G, et al. Among authors: berrutti m. J Lipid Res. 2017 Jun;58(6):1221-1229. doi: 10.1194/jlr.M075028. Epub 2017 Feb 27. J Lipid Res. 2017. PMID: 28242789 Free PMC article.
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
Musso G, Cassader M, De Michieli F, Paschetta E, Pinach S, Saba F, Bongiovanni D, Framarin L, Berrutti M, Leone N, Corvisieri S, Parente R, Molinaro F, Sircana A, Bo S, Gambino R. Musso G, et al. Among authors: berrutti m. Hum Mol Genet. 2017 May 1;26(9):1785. doi: 10.1093/hmg/ddx126. Hum Mol Genet. 2017. PMID: 28398481 No abstract available.
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
Musso G, Saba F, Cassader M, Paschetta E, De Michieli F, Pinach S, Framarin L, Berrutti M, Leone N, Parente R, Ayoubi Khajekini MT, Zarovska A, Gambino R. Musso G, et al. Among authors: berrutti m. Am J Gastroenterol. 2019 Apr;114(4):607-619. doi: 10.14309/ajg.0000000000000154. Am J Gastroenterol. 2019. PMID: 30920415 Free article.
New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis-Related Kidney Disease.
Musso G, De Michieli F, Bongiovanni D, Parente R, Framarin L, Leone N, Berrutti M, Gambino R, Cassader M, Cohney S, Paschetta E. Musso G, et al. Among authors: berrutti m. Clin Gastroenterol Hepatol. 2017 Jul;15(7):972-985. doi: 10.1016/j.cgh.2016.08.002. Epub 2016 Aug 10. Clin Gastroenterol Hepatol. 2017. PMID: 27521506 Free article. Review.
Gut microbiota, hypertension and chronic kidney disease: Recent advances.
Sircana A, De Michieli F, Parente R, Framarin L, Leone N, Berrutti M, Paschetta E, Bongiovanni D, Musso G. Sircana A, et al. Among authors: berrutti m. Pharmacol Res. 2019 Jun;144:390-408. doi: 10.1016/j.phrs.2018.01.013. Epub 2018 Jan 31. Pharmacol Res. 2019. PMID: 29378252 Review.
Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana A, Framarin L, Leone N, Berrutti M, Castellino F, Parente R, De Michieli F, Paschetta E, Musso G. Sircana A, et al. Among authors: berrutti m. Curr Diab Rep. 2018 Sep 13;18(10):98. doi: 10.1007/s11892-018-1057-6. Curr Diab Rep. 2018. PMID: 30215149 Review.
37 results